| Position | Action |
|---|---|
| Current signal conviction (MACD histogram +0.04) | Zero trim — maintain market weight |
| Post-Q3 earnings validation of $7.70 EPS as sustainable run-rate | Reassess for potential upgrade to overweight |
| Breakout above $362.58 | Do NOT pre-emptively chase — wait for pullback to $340-347 |
| Hard stop breach at $330 (50 SMA / structural trend line) | Exit position |
JPMorgan's record-breaking Q2 2026 earnings, 17.8% ROE, and $750B housing initiative create a compounding franchise that deserves premium positioning now rather than waiting for a pullback that may never materialize.
| Indicator | Value | Signal |
|---|---|---|
| Price (Close) | $359.24 | neutral |
| 50 SMA | $330.08 | bullish |
| 200 SMA | $310.18 | bullish |
| 50 vs 200 Spread | +$19.90 (Golden Cross) | bullish |
| MACD Line | 7.24 | bullish |
| MACD Signal Line | 7.21 | bullish |
| MACD Histogram | +0.04 | neutral |
| RSI (14) | 66.03 | bullish |
| RSI Recent Peak | 72.10 (2026-06-17) | neutral |
| Bollinger Upper Band | $362.58 | neutral |
| Bollinger Middle (20 SMA) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Hold JPM at Market Weight — No Fresh Capital Deployment at 99th Percentile of 52-Week Range
The consensus across the Research Manager, Trader, and prior lessons converges on Market Weight: the aggressive analyst's franchise-quality case (17.8% ROE, $48B annual capital return, 14.4x fwd P/E, 5%+ shareholder yield) is intellectually sound but commits the 7/30 category error of conflating business quality with entry-point attractiveness. At the 99th percentile of the 52-week range with RSI 66 and a flattening MACD histogram (+0.04), the asymmetric setup is against adding. The $330 hard stop (50 SMA / structural trend line) and the $340-347 re-entry zone provide clear mechanical boundaries. Q3 earnings mid-October resolves contested data points (EPS sustainability, trading revenue normalization, NIM trajectory) and is the only legitimate re-rating catalyst pre-earnings. The +30.7% QoQ net debt expansion and +27.9% QoQ trading securities expansion add real leverage risk if the cycle turns, reinforcing that the conservative 7-11% upside vs 14-22% downside asymmetry does not justify aggressive capital deployment at this entry point.
When: Confirmed breakout above $362.58 with volume validation
Then: Post-breakout reassessment — do not pre-emptively add
↩ rebuts: “Not a one-time splurge but long-duration capital deployment that compounds”
· concedes: Bear correctly identifies price near upper Bollinger Band ($362.58) at $359.24; Bear correctly notes net debt up $48B QoQ; Bear correctly identifies Dimon has warned about broad market valuation; Stock is near 52-week high with limited short-term pullback potential
A great company can still be a bad stock to buy at the wrong price; JPM is priced for perfection at the top of a 52-week range while underlying risks (cyclical earnings, leverage expansion, consumer credit deterioration, CRE exposure, macro tailwinds reversing) are quietly compounding.
→ vs conservative: 99th percentile reading and RSI approaching 70 misread as trim signal; balance sheet expansion is offensive capital deployment during benign macro window, not distress
→ vs neutral: Hedging at $359 and treating as coin flip ignores fortress balance sheet quality and asymmetric breakout setup; waiting for pullback risks missing 5% extension
→ vs neutral: Trailing stop anchored to 50 SMA at $330 gives ~8% risk against measured move above $375, nearly 2-to-1 reward-to-risk that caution crowd ignores
→ vs conservative: Dimon warning about S&P 500/Treasuries signals relative value favor of JPM at 14 forward multiple with 5% yield vs overvalued bonds and equities
| $347.31 |
| bullish |
| Bollinger Lower Band | $332.04 | bullish |
| Bollinger Band Width | ~$30.54 | neutral |
| ATR (14) | $7.26 | neutral |
| ATR Range (2-month) | ~$6.25 to $8.02 | neutral |
| VWMA (20) | $349.79 | bullish |
| Price vs VWMA | +2.7% | bullish |
| 50 SMA July 8 Support Test | ~$312.78 (low touched $330.13) | bullish |
Support: 347.31 · 332.04 · 330.08 · 310.18 | Resistance: 362.58 · 370 · 375
The technical analysis reveals JPM in a confirmed strong uptrend with the 50 SMA firmly above the 200 SMA (golden cross intact, $19.90 spread) and price well above both averages (+8.8% and +15.8% respectively). The MACD bull cross remains in place but momentum is decelerating (histogram near zero), while RSI at 66 sits in bullish-but-not-overbought territory with prior peaks at 71-72 not triggering immediate reversals. Bollinger Bands show price near the upper band ($362.58) with the lower band ($332.04) acting as a pullback floor; ATR of $7.26 indicates normal trending volatility. VWMA rising in tandem with price confirms accumulation. The recommendation is HOLD with bias to add on pullbacks to $340-$347 zone, using 50 SMA ($330.08) as the primary structural stop and approximately 2× ATR ($14.50) as the tactical stop-loss.
Market Cap
$954.9B
Share Price (TTM-implied)
$359
52-Week Range
$279.10 – $362.17
50-Day Avg
$328.70
200-Day Avg
$312.11
Beta
0.977
P/E (TTM)
15.39x
Forward P/E
14.37x
P/B
2.70x
PEG
1.72
Dividend Yield
1.70%
EPS (TTM)
$23.35
Forward EPS
$25.01
Book Value/Share
$133.01
Total Revenue FY2025
$181,847M
Net Interest Income FY2025
$95,443M
Net Income FY2025
$57,048M
Diluted EPS FY2025
$20.02
Pretax Income FY2025
$72,595M
Effective Tax Rate FY2025
21.4%
Net Margin
34.9%
Operating Margin
50.4%
ROE
17.79%
ROA
1.36%
Revenue 3Y CAGR (FY22→FY25)
~12.4%
EPS 3Y CAGR (FY22→FY25)
~18.4%
Tangible Book Value CAGR
~8%
Total Assets Q1 2026
$4,900.5B
Stockholders' Equity Q1 2026
$364.0B
Tangible Book Value Q1 2026
$279.7B
Total Debt Q1 2026
$516.8B
Net Debt Q1 2026
$204.7B
Cash Dividends FY2025
$16.6B
Common Stock Repurchases FY2025
$31.6B
Total Capital Return FY2025
~$48.2B
Q2 2026 Revenue
$49.83B
Q2 2026 Net Income
$16.49B
Q2 2026 Diluted EPS
$7.70
Q2 2026 Pretax Income
$20.48B
Q2 2026 Net Interest Income
$25.37B
Efficiency Ratio
~33%
Treasury Stock Q1 2026
~$172B
Share Count Reduction
~9%
Strengths
Concerns
JPMorgan Chase remains the gold-standard U.S. money-center bank with industry-leading 17.8% ROE, record Q2 2026 earnings momentum (EPS +47% YoY), and ~$48B annual capital return. While valuation (15.4x P/E) is reasonable and forward P/E of 14.4x is attractive given the ROE, the stock is trading near its 52-week high with limited room for multiple expansion. The asset growth surge (+15% QoQ in Q1 2026) and net debt jump (+31% QoQ) warrant monitoring for credit normalization. Recommendation: HOLD for existing holders; new entries may prefer a pullback toward the 50-day moving average ($329).